Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Riverfolk

V.ARCH

Peptides Vs Antibodies

Antibody drugs such as these typically display more specific receptor...

October 25, 2022

V.ARCH

Arch - Novel Antibodies

Arch Biopartners files new patent application for novel antibody candidates...

October 25, 2022

V.ARCH

Novo Executive Joined Arch team - Novo Researching Peptides

Novo Research Technologies Proteins and peptides ...

October 25, 2022

V.ARCH

News - Novo Nordisk Executive Joins Arch Biopartners

Farris Smith, Executive with Novo Nordisk joins Arch Biopartners as a...

October 6, 2022

V.HCH

HCH - Rick Rule Interview CE

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

September 1, 2022

V.HCH

HCH - Rick Rules Symposium

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

September 1, 2022

V.ARCH

Arch Biopartners 94% Upside Potential

Arch Biopartners 94% Upside Potential

July 7, 2022

V.ARCH

Globe says Arch seen having "blockbuster potential"

The Globe and Mail reports in its Thursday edition that iA Capital analyst...

July 7, 2022

V.ARCH

Healthcare - Analyst Coverage - Arch Biopartners

Arch Biopartners - Target $6

July 6, 2022

V.ARCH

Arch Biopartners - My Due Diligence

Arch Biopartners Inc. (“Arch” or the “Company”) is a portfolio-based...

June 7, 2022

V.ARCH

Arch - Phase III Human Clinical Trial

https://www.archbiopartners.com/our-science/metablok/

April 18, 2022

V.ARCH

Current Market Cap Industry Peers:

Arch - $253,000,000 @ $4.07  Positive Phase II Data ( Organ Inflammation...

April 18, 2022

V.ARCH

Arch Biopartners - My Due Diligence

Arch Biopartners - My Due Diligence Arch Biopartners Inc. (“Arch” or the...

April 18, 2022

V.ARCH

Arch - Fully Funded Phase III Clinical Trial

ClinicalTrial.gov CATCO LSALT PHASE III

April 4, 2022

V.ARCH

Arch - Dramatically Undervalued in comparison to its peers

Current Market Cap Industry Peers: Arch - $223,000,000 @ $3.60 ...

March 21, 2022

V.ARCH

Arch - Dramatically Undervalued in comparison to its peers

Current Market Cap Industry Peers: Arch - $219,000,000 @ $3.55 ...

March 17, 2022

V.ARCH

Arch - Motley Fool - Retirement Planning

Retirement Planning: 3 Unusual Bets That Could Pay Off Huge

March 17, 2022

V.ARCH

Arch Biopartners - My Due Diligence (NEW)

Arch Biopartners Inc. (“Arch” or the “Company”) is a portfolio-based...

March 16, 2022

V.ARCH

Alberta-based research may have breakthough on kidney treatm

Alberta-based research may have breakthrough on kidney treatment

March 12, 2022

V.ARCH

first-ever signal towards validating Dipeptidase-1

Phase II results provide a first-ever signal towards validating Dipeptidase-1...

March 4, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Desert Gold Ventures Inc.

Desert Gold Ventures Inc. V.DAU

Desert Gold Ventures Inc. is a gold exploration and development company which controls the approximately 440 square ... view more »